Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4, Pragmatic, Randomized Trial to Evaluate the Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years

NCT07790523 is registered in ClinicalTrials.gov with Tor Biering-Sørensen as lead sponsor.

NCT NCT07790523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07790523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4, Pragmatic, Randomized Trial to Evaluate the Effectiveness of An Influenza/COVID-19 Vaccine (mCombriax [mRNA-1083]) in Adults ≥ 65 Years
Lead sponsor
Tor Biering-Sørensen
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2028
Enrollment
Not reported
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, influenza